Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Miguel López Moreno, PhD
CONTACT
Lead
Miguel López Moreno
With
Metabolic dysfunction-associated liver disease (MetLD) is currently the most prevalent chronic liver disease worldwide, representing the hepatic manifestation of metabolic syndrome and closely associated with obesity, type 2 diabetes mellitus, dyslipidemia, and hypertension. Its global burden continues to rise in parallel with increasing rates of cardiometabolic disorders, posing a major public health challenge. The natural history of MetLD ranges from simple steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Disease progression is influenced by a complex interplay of metabolic, genetic, environmental, and lifestyle-related factors. Lifestyle modification remains the cornerstone of MetLD management, with dietary intervention being a key therapeutic strategy. Current clinical guidelines recommend the Mediterranean diet as the standard dietary approach, given its demonstrated benefits in reducing hepatic steatosis, improving insulin sensitivity, lowering systemic inflammation, and enhancing overall cardiometabolic health. Notably, these benefits have been observed even in the absence of substantial weight loss. In recent years, plant-based dietary patterns have gained increasing attention due to their potential to further improve metabolic and hepatic outcomes. Diets rich in plant-derived foods are characterized by higher intakes of dietary fiber, polyphenols, antioxidants, and unsaturated fatty acids, alongside lower intakes of saturated fats and cholesterol. These nutritional characteristics may contribute to improved insulin sensitivity, modulation of lipid metabolism, and attenuation of chronic low-grade inflammation. Furthermore, plant-based diets may influence liver health through mechanisms beyond traditional metabolic pathways. Emerging evidence highlights the role of environmental contaminants and endocrine-disrupting chemicals in the pathogenesis and progression of MetLD. Compounds such as per- and polyfluoroalkyl substances (PFAS) and heavy metals (e.g., cadmium, lead, mercury) have been associated with oxidative stress, mitochondrial dysfunction, alterations in glucose and lipid homeostasis, and hepatic injury. These contaminants are known to bioaccumulate predominantly in animal-derived foods, including fish, seafood, red meat, and organ meats. Therefore, dietary patterns that reduce or eliminate animal-based foods may lower internal exposure to these harmful substances. In addition to environmental exposures, genetic susceptibility and gut microbiota composition play critical roles in MetLD development and progression. Genetic variants such as PNPLA3, TM6SF2, MBOAT7, GCKR, and HSD17B13 have been consistently associated with liver fat accumulation, inflammation, and fibrosis. Meanwhile, the gut microbiota acts as a key regulator of host metabolism and immune function through the gut-liver axis, influencing bile acid metabolism, short-chain fatty acid production, and inflammatory signaling pathways. Diet is one of the main determinants of microbiota composition and function, and plant-based diets have been associated with increased microbial diversity and beneficial metabolic profiles. Despite these advances, there is currently a lack of randomized clinical trials specifically evaluating the effects of a Mediterranean diet exclusively based on plant-derived foods in patients with MetLD, particularly considering the integrated assessment of hepatic outcomes, cardiometabolic risk factors, gut microbiota, genetic susceptibility, and environmental contaminant exposure. This study is a randomized, controlled, parallel-group clinical trial designed to compare the effects of two dietary interventions: (1) a traditional Mediterranean diet, which includes both plant- and animal-based foods and is considered the standard of care in this setting, and (2) a Mediterranean diet exclusively based on plant-derived foods. Participants will be randomly allocated in a 1:1 ratio using a computer-generated randomization sequence with stratification by age and sex. The intervention will last 12 weeks, followed by a 4-week post-intervention follow-up period aimed at evaluating adherence, sustainability, and integration of lifestyle changes. The study adopts a pragmatic design to enhance external validity, allowing participants to follow ad libitum dietary intake within structured dietary guidelines, guided by internal hunger and satiety cues rather than strict caloric prescriptions. All participants will undergo a comprehensive baseline assessment, including clinical evaluation, dietary assessment, anthropometric measurements, blood pressure, and non-invasive liver evaluation using transient elastography with controlled attenuation parameter (CAP). Biological samples (blood, urine, feces, and hair) will be collected at baseline and at the end of the intervention to allow intra-individual comparisons. Dietary interventions will be individually tailored by registered dietitians based on participants' clinical characteristics, preferences, and estimated energy requirements. Both dietary patterns will emphasize whole, minimally processed foods and adherence to Mediterranean dietary principles. The plant-based intervention group will exclude all animal-derived foods and will receive standardized vitamin B12 supplementation to prevent deficiencies. Dietary intake will be monitored through repeated 24-hour dietary recalls conducted at multiple time points throughout the intervention, including both weekdays and weekends. Participants will also provide photographic records of meals to enhance data accuracy. Nutrient intake will be analyzed using specialized dietary analysis software. Continuous dietary counseling and support will be provided to promote adherence. Comprehensive outcome assessments will include biochemical, metabolic, inflammatory, and functional parameters. Laboratory analyses will include liver enzymes, lipid profile, glucose metabolism markers, iron status, and systemic inflammatory markers such as C-reactive protein and the neutrophil-to-lymphocyte ratio. Environmental exposure assessment will include quantification of PFAS in serum samples using high-performance liquid chromatography coupled with tandem mass spectrometry and isotopic dilution techniques. Heavy metals will be measured in hair samples using inductively coupled plasma mass spectrometry (ICP-MS/MS), providing an estimate of chronic exposure. Gut microbiota composition will be analyzed using 16S rRNA gene sequencing, focusing on diversity indices, taxonomic composition, and functional profiles. Genetic analyses will be performed on blood samples to identify polymorphisms associated with MetLD susceptibility and progression. Standardized and validated questionnaires will be used to assess physical activity, adherence to the Mediterranean diet, and quality of life. Additionally, body composition will be evaluated using bioelectrical impedance analysis, and muscle strength will be assessed using handgrip dynamometry. The primary objective of the study is to evaluate the effect of a plant-based Mediterranean diet on liver health, assessed non-invasively through elastographic and biochemical parameters. Secondary objectives include the evaluation of changes in anthropometric and cardiometabolic parameters, systemic inflammation, gut microbiota composition, genetic modulation of dietary response, and internal exposure to environmental contaminants. Data will be collected and managed using a secure electronic data capture system, ensuring data quality, confidentiality, and compliance with regulatory standards. Statistical analyses will be performed using appropriate descriptive and inferential methods, including multivariate regression models to account for potential confounders. The study will be conducted in accordance with the principles of Good Clinical Practice and the Declaration of Helsinki. Ethical approval will be obtained from the relevant institutional review board, and all participants will provide written informed consent prior to inclusion. This study is expected to provide novel, integrative evidence on the role of dietary patterns in modulating liver health, metabolic function, environmental exposures, and host-microbiome interactions. The findings may contribute to the development of more effective, sustainable, and personalized nutritional strategies for the prevention and management of MetLD, supporting the integration of precision nutrition and planetary health into clinical practice.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
